These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 8495424)
21. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis. de Anta JM; Jassem E; Rosell R; Martínez-Roca M; Jassem J; Martínez-López E; Monzó M; Sánchez-Hernández JJ; Moreno I; Sánchez-Céspedes M Oncogene; 1997 Dec; 15(24):2951-8. PubMed ID: 9416838 [TBL] [Abstract][Full Text] [Related]
22. Mutations of p53 gene in gastric carcinoma in Taiwan. Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797 [TBL] [Abstract][Full Text] [Related]
23. Morphologic, histologic, and molecular similarities between adenocarcinomas arising in the gastric stump and the intact stomach. Safatle-Ribeiro AV; Ribeiro Júnior U; Reynolds JC; Gama-Rodrigues JJ; Iriya K; Kim R; Bakker A; Swalsky PA; Pinotti HW; Finkelstein SD Cancer; 1996 Dec; 78(11):2288-99. PubMed ID: 8940997 [TBL] [Abstract][Full Text] [Related]
24. p53 mutation is a common genetic event in ovarian carcinoma. Milner BJ; Allan LA; Eccles DM; Kitchener HC; Leonard RC; Kelly KF; Parkin DE; Haites NE Cancer Res; 1993 May; 53(9):2128-32. PubMed ID: 8481915 [TBL] [Abstract][Full Text] [Related]
25. p53 mutation, allele loss on chromosome 17p, and DNA content in ovarian carcinoma. McManus DT; Murphy M; Arthur K; Hamilton PW; Russell SE; Toner PG J Pathol; 1996 Jun; 179(2):177-82. PubMed ID: 8758210 [TBL] [Abstract][Full Text] [Related]
26. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors. Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030 [TBL] [Abstract][Full Text] [Related]
27. P53 mutations in colorectal cancer assessed in both genomic DNA and cDNA as compared to the presence of p53 LOH. Forslund A; Kressner U; Lönnroth C; Andersson M; Lindmark G; Lundholm K Int J Oncol; 2002 Aug; 21(2):409-15. PubMed ID: 12118339 [TBL] [Abstract][Full Text] [Related]
28. Mutations in the tumor suppressor gene p53 in human liver cancer induced by alpha-particles. Andersson M; Jönsson M; Nielsen LL; Vyberg M; Visfeldt J; Storm HH; Wallin H Cancer Epidemiol Biomarkers Prev; 1995; 4(7):765-70. PubMed ID: 8672994 [TBL] [Abstract][Full Text] [Related]
29. Accumulating mutations of p53 in colon tumor and hairy cell leukemia do not arise from methylation/deamination processes, but rather from nucleotide deletions and insertions. Marcsek ZL; König EA Biol Chem; 1998; 379(4-5):545-7. PubMed ID: 9628350 [TBL] [Abstract][Full Text] [Related]
30. Genetic evidence for the multicentric origin of synchronous multiple gastric carcinoma. Kang GH; Kim CJ; Kim WH; Kang YK; Kim HO; Kim YI Lab Invest; 1997 Mar; 76(3):407-17. PubMed ID: 9121123 [TBL] [Abstract][Full Text] [Related]
31. p53 mutations and microsatellite instability in sporadic gastric cancer: when guardians fail. Strickler JG; Zheng J; Shu Q; Burgart LJ; Alberts SR; Shibata D Cancer Res; 1994 Sep; 54(17):4750-5. PubMed ID: 8062274 [TBL] [Abstract][Full Text] [Related]
32. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene. Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735 [TBL] [Abstract][Full Text] [Related]
33. The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern. Takahashi T; Takahashi T; Suzuki H; Hida T; Sekido Y; Ariyoshi Y; Ueda R Oncogene; 1991 Oct; 6(10):1775-8. PubMed ID: 1656362 [TBL] [Abstract][Full Text] [Related]
34. [p53 gene mutation in cancer of the colon and rectum]. Roa JC; Roa I; Melo A; Araya JC; Villaseca MA; Flores M; Schneider B Rev Med Chil; 2000 Sep; 128(9):996-1004. PubMed ID: 11349504 [TBL] [Abstract][Full Text] [Related]
35. P53 gene mutation spectrum and the relationship between gene mutation and protein levels in pterygium. Tsai YY; Cheng YW; Lee H; Tsai FJ; Tseng SH; Chang KC Mol Vis; 2005 Jan; 11():50-5. PubMed ID: 15682042 [TBL] [Abstract][Full Text] [Related]
36. Sites and types of p53 mutations in an unselected series of colorectal cancers in The Netherlands. Van Den Broek MH; Renault B; Fodde R; Verspaget H; Griffioen G; Khan PM Anticancer Res; 1993; 13(3):587-92. PubMed ID: 8317886 [TBL] [Abstract][Full Text] [Related]
37. [Mutations of the p53 suppressor gene in gastric adenocarcinoma]. Aranda M; Náquira N; Karque R; Mendoza H; Sepúlveda C; Silva C Rev Med Chil; 1998 May; 126(5):525-32. PubMed ID: 9731434 [TBL] [Abstract][Full Text] [Related]
38. [Tumour suppressor p53 gene sequence mutations in pleomorphic adenoma of salivary gland]. Wang J; Dong F; Yong P Zhonghua Yi Xue Za Zhi; 1999 Oct; 79(10):777-9. PubMed ID: 11715527 [TBL] [Abstract][Full Text] [Related]
39. Mutations in the retinoblastoma gene and their expression in somatic and tumor cells of patients with hereditary retinoblastoma. Kato MV; Ishizaki K; Toguchida J; Kaneko A; Takayama J; Tanooka H; Kato T; Shimizu T; Sasaki MS Hum Mutat; 1994; 3(1):44-51. PubMed ID: 8118465 [TBL] [Abstract][Full Text] [Related]
40. Methylation and repeats in silent and nonsense mutations of p53. Kouidou S; Malousi A; Maglaveras N Mutat Res; 2006 Jul; 599(1-2):167-77. PubMed ID: 16620878 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]